Concepedia

P. Miossec

PM

Statistics

Publications

12

Citations

1.2K

H-Index

11

Active since

1998

Affiliations

Sanofi (France)(Current)

Sanofi (Germany)

Hôpital Jean-Verdier

Dallas Diabetes Research Center

Sanofi (United States)

P. Miossec is an author at Sanofi (France) specializing in diabetes mellitus, pharmacotherapy, and clinical pharmacology.

Publications per year

1998–2022

12

Publications

12

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin

Matthew C. Riddle, Ronnie Aronson, Philip Home et al. · Diabetes Care · 2013 · 285 citations · Full text

, , +17

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin

Julio Rosenstock, D. Raccah, László Korányi et al. · Diabetes Care · 2013 · 250 citations · Full text

, , +17

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy

Vivian Fonseca, Ricardo Alvarado-Ruiz, D. Raccah et al. · Diabetes Care · 2012 · 218 citations · Full text

, , +16

Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M)

Bo Åhrén, Aniceto Leguizamo Dimas, P. Miossec et al. · Diabetes Care · 2013 · 171 citations · Full text

, , +15

Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)

Julio Rosenstock, M Hanefeld, Paramesh Shamanna et al. · Journal of Diabetes and its Complications · 2014 · 126 citations · Full text

, , +13

1–5 of 12